ArticlePharmaceutics2022

Optimization of the Solvent and In Vivo Administration Route of Auranofin in a Syngeneic Non-Small Cell Lung Cancer and Glioblastoma Mouse Model.

Laurie Freire Boullosa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.